Try our mobile app

Published: 2022-06-02 21:53:04 ET
<<<  go to RDY company page
EX-99.2 2 drr0395_ex99-2.htm EXHIBIT 99.2

 

Exhibit 99.2

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN : L85195TG1984PLC004507

 

Tel      :+91 40 4900 2900

Fax     :+91 40 4900 2999

Email :mail@drreddys.com

www.drreddys.com

 

June 2, 2022

 

New York Stock Exchange (NYSE) (Scrip code: RDY)

Securities Exchange Commission, USA

 

Dear Sir / Madam,

 

Sub: Intimation regarding alteration of Memorandum and Articles of Association pursuant to approval of the Scheme of Amalgamation and Arrangement

 

This is further to our letter dated April 22, 2022. Attached is a certified copy of the Memorandum and Articles of Association altered pursuant to approval of the Scheme of Amalgamation and Arrangement.

 

Below is an extract of the alteration –

 

V. a. The authorised share capital of the company is INR.145,00,00,000/- (Rs. One Hundred and Forty-five Crores Only) divided into 29,00,00,000 (Twenty-Nine crores) equity shares of INR 5/- (Rupees Five only) each.*

 

b. The company has power from time to issue shares, Hybrids, Derivatives, Options, Quasi-equity instruments, with differential rights, or to increase, consolidate, sub-divide, exchange, reduce and also to purchase any of its shares whether or not redeemable and to make payments out of its capital in respect of such purchase or otherwise alter its share capital as equity or non-voting equity shares or preference shares and to attach to any classes of such shares preferences, rights, privileges or priorities in payment of dividends or distribution of assets or otherwise, over any other shares and to subject the same to any restriction, limitation or condition and to vary the regulation of the company, as for apportioning the right to participate in profits in any manner subject to the provision of the Act and consent of the appropriate authorities if required, being obtained before doing so.

 

* Amended pursuant to the Scheme of Amalgamation and Arrangement approved by the Hon'ble National Company Law Tribunal, Hyderabad Bench, vide order dated April 5,2022. The Scheme was effective from April 8, 2022.

 

This is for your information.

 

Thanking You.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

     
/s/ K Randhir Singh    
K Randhir Singh    
Company Secretary & Compliance Officer